Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pliant Therapeutics Inc.

    NASDAQ: PLRX · Real-Time Price · USD
    1.31
    0.01 (0.77%)
    At close: Jun 25, 2025, 1:12 PM

    Pliant Therapeutics Statistics

    Share Statistics

    Pliant Therapeutics has 61.39M shares outstanding. The number of shares has increased by 1.51% in one year.

    Shares Outstanding

    n/a
    		 61.39M

    Shares Change (YoY)

    n/a
    		 1.51%

    Shares Change (QoQ)

    n/a
    		 0.63%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 54.04M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,967

    FTD / Avg. Volume

    n/a
    		 0.59%

    Short Selling Information

    The latest short interest is 3.92M, so 6.39% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.92M

    Short % of Shares Out

    n/a
    		 6.39%

    Short % of Float

    n/a
    		 6.54%

    Short Ratio (days to cover)

    n/a
    		 2.96

    Valuation Ratios

    The PE ratio is -3.79 and the forward PE ratio is -0.65. Pliant Therapeutics's PEG ratio is -0.14.

    PE Ratio

    n/a
    		 -3.79

    Forward PE

    n/a
    		 -0.65

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 2.62

    P/FCF Ratio

    n/a
    		 -5

    PEG Ratio

    n/a
    		 -0.14
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Pliant Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.91, with a Debt / Equity ratio of 0.2.

    Current Ratio

    n/a
    		 10.91

    Quick Ratio

    n/a
    		 10.91

    Debt / Equity

    n/a
    		 0.2

    Debt / EBITDA

    n/a
    		 -0.26

    Debt / FCF

    n/a
    		 -0.38

    Interest Coverage

    n/a
    		 -75.52

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,229,847.95

    Employee Count

    n/a
    		 171

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -88% in the last 52 weeks. The beta is 1.36, so Pliant Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.36

    52-Week Price Change

    n/a
    		 -88%

    50-Day Moving Average

    n/a
    		 1.44

    200-Day Moving Average

    n/a
    		 7.69

    Relative Strength Index (RSI)

    n/a
    		 40.02

    Average Volume (20 Days)

    n/a
    		 1,016,591

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -228.37M

    Net Income

    n/a
    		 -210.3M

    EBITDA

    n/a
    		 -228.37M

    EBIT

    n/a
    		 -189.22M

    Earnings Per Share (EPS)

    n/a
    		 -3.47
    Full Income Statement

    Balance Sheet

    The company has 71.19M in cash and 60.19M in debt, giving a net cash position of 11M.

    Cash & Cash Equivalents

    n/a
    		 71.19M

    Total Debt

    n/a
    		 60.19M

    Net Cash

    n/a
    		 11M

    Retained Earnings

    n/a
    		 -710.05M

    Total Assets

    n/a
    		 344.77M

    Working Capital

    n/a
    		 282.99M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -155.5M and capital expenditures -3.85M, giving a free cash flow of -159.35M.

    Operating Cash Flow

    n/a
    		 -155.5M

    Capital Expenditures

    n/a
    		 -3.85M

    Free Cash Flow

    n/a
    		 -159.35M

    FCF Per Share

    n/a
    		 -2.63
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PLRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PLRX is $3, which is 129% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $3

    Price Target Difference

    n/a
    		 129%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 10
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -3.66

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist